Otolith Labs’ at-home study is a research study conducted via telehealth. The study is for individuals diagnosed with vestibular migraine and is testing the efficacy of our investigational wearable device intended to manage the symptoms of vertigo. We are working with a select 17 clinics to recruit. If you are from one of our referring clinics, please refer to your clinic-specific materials or contact a clinical coordinator at your site for more information. Online enrollment has closed.

Learn more: ClinicalTrials.gov ID NCT06267924

Otolith Labs’ technology has been tested in trials with over 500 participants, and there have been zero serious device-related adverse events. We are nearing the conclusion of two clinical studies, which we aim to make public soon. We thank the outstanding healthcare providers, clinics, and patients we work with daily. This breakthrough work will be seminal in our upcoming De Novo filing with the FDA. We look forward to sharing our continued findings in-depth in support of peer-reviewed and edited scientific journals.